Inductively Coupled Plasma Mass Spectrometry─A Valid Method for the Characterization of Metal Conjugates in View of the Development of Radiopharmaceuticals-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inductively Coupled Plasma Mass Spectrometry─A Valid Method for the Characterization of Metal Conjugates in View of the Development of Radiopharmaceuticals

Published:2023-02-24 Issue:4 Volume:20 Page:2150-2158
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Wallimann Rahel H.¹²,Schindler Patrick¹,Hensinger Heloïse¹,Tschan Viviane J.³,Busslinger Sarah D.³,Kneuer Rainer¹,Müller Cristina²³^ORCID,Schibli Roger²³^ORCID

Affiliation:

1. Novartis Institutes for Biomedical Research, Novartis, 4056 Basel, Switzerland

2. Department of Chemistry and Applied Biosciences, ETH Zurich, 8093 Zurich, Switzerland

3. Center for Radiopharmaceutical Sciences, ETH-PSI, Paul Scherrer Institute, 5232 Villigen, Switzerland

Funder

Schweizerischer Nationalfonds zur F?rderung der Wissenschaftlichen Forschung

Personalized Medicine and Related Technology

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.2c01092

Reference33 articles.

1. Radiotheranostics - Precision Medicine in Nuclear Medicine and Molecular Imaging

2. 68Ga-PSMA-11 NDA Approval: A Novel and Successful Academic Partnership

3. Phase III study of lutetium-177-PSMA-617 in patients with metastatic castration-resistant prostate cancer (VISION).

4. Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer

5. [177Lu]Lu-PSMA-617 (PluvictoTM): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liquid Chromatography ICP-MS to Assess the Stability of 175Lu- and natGa-Based Tumor-Targeting Agents towards the Development of 177Lu- and 68Ga-Labeled Radiopharmaceuticals;Pharmaceutics;2024-02-21

2. Synthesis and Preclinical Evaluation of Radiolabeled [103Ru]BOLD-100;Pharmaceutics;2023-11-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3